Palliative radiotherapy for symptomatic hepatocellular carcinoma improves survival in HCC or liver metastases

Share :
Published: 7 Feb 2023
Views: 92
Rating:
Save
Prof Laura Dawson - University of Toronto, Toronto, Canada

Prof Laura Dawson speaks to ecancer about a phase III study of palliative radiotherapy for symptomatic hepatocellular carcinoma and liver metastases.

The trial investigated if more patients with painful liver cancer have improved pain 1 month following radiation therapy, compared to best supportive care (BSC).

The study found that single fraction RT improves hepatic pain in the majority of patients with end-stage HCC or liver metastases, with a trend to improved survival.